Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.

/in
Goepfert PA, Elizaga ML, Seaton KE, et al.; HVTN 205 Study Group; National Institutes of Allergy and Infectious Diseases HIV Vaccine Trials Network (Dolin R). Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles. J Infect Dis. 2014 July;210(1):99-110. PMCID: PMC4072895. [Article]